YM155, also known as sepantronium bromide, suppresses Survivin expression by downregulating transcriptional activity at the Survivin promoter [139] and inhibits proliferation and promotes apoptosis in medulloblastoma [140], glioma [141, 142] and neuroblastoma cell lines in vitro [143, 144]. This evidence concerns the gene BIRC5 and central nervous system cancer.